Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation on May 9, 2013, regarding events occurring on May 6, 2013. The filing addresses a leadership transition at Lifecore Biomedical, LLC, a wholly-owned subsidiary of Landec Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance and personnel changes.
Material Changes
The primary material change reported is the departure of a senior executive:
- Dennis J. Allingham notified the Company of his retirement effective June 1, 2013.
- He tendered his resignation as Vice President of Landec Corporation.
- He also resigned as President and Chief Executive Officer of Lifecore Biomedical, LLC.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. The document strictly reports the notification of retirement and resignation.
Investor Verification Checklist
- Confirm the appointment of a successor to Dennis J. Allingham for the roles of VP of Landec Corporation and CEO of Lifecore Biomedical, LLC.
- Review subsequent filings to determine if this leadership change impacts the strategic direction of the Lifecore Biomedical subsidiary.
- Verify if any compensatory arrangements were made in connection with Mr. Allingham's retirement, as this item is often disclosed in conjunction with Item 5.02.